β-Cell function in type 2 diabetes.

Area of Science:

• Endocrinology
• Metabolic Diseases
• Computational Biology

Background:

• Assessing beta-cell (β-cell) function in vivo is complex due to modest correlations between various insulin secretion indices.
• No single in vivo test accurately reflects overall β-cell function compared to insulin sensitivity.
• Mathematical modeling is crucial for interpreting β-cell secretory responses.

Purpose of the Study:

• To highlight the necessity of physiologically-based mathematical modeling for accurate β-cell function assessment.
• To differentiate the roles of various tests in evaluating β-cell responses.
• To define key parameters of β-cell function, particularly glucose sensitivity, in relation to type 2 diabetes.

Main Methods:

• Analysis of intravenous and oral glucose tests using physiologically-based mathematical models.
• Evaluation of insulin secretion indices and their correlation with insulin sensitivity.
• Characterization of β-cell glucose sensitivity and its role in type 2 diabetes pathophysiology.

Main Results:

• Mathematical modeling is essential for interpreting β-cell function from secretory responses.
• Oral glucose or mixed meal tests may offer simpler and more physiologically relevant data than intravenous tests.
• Reduced β-cell glucose sensitivity, not necessarily mass, is a hallmark of type 2 diabetes, often compensated by increased insulin secretion rates.
• Impaired incretin effect accompanies reduced glucose sensitivity in type 2 diabetes.

Conclusions:

• Accurate assessment of β-cell function necessitates physiologically-based mathematical modeling.
• Reduced β-cell glucose sensitivity is a key functional defect in type 2 diabetes, potentially reversible.
• Interventions improving glucose tolerance primarily enhance β-cell glucose sensitivity, though modifying the natural course of dysfunction remains challenging.